Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. - Wikidata - wikimedia - TriplyDB

Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

http://www.wikidata.org/entity/Q36542587

about

Avian Mycobacteriosis: Still Existing Threat to Humans Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis Managing pulmonary nontuberculous mycobacterial infection. time for a patient-centered approach.Understanding nontuberculous mycobacterial lung disease: it's been a long time coming Current treatment of atypical mycobacteriosis Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections Advantages and drawbacks of long-term macrolide use in the treatment of non-cystic fibrosis bronchiectasis.Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease.Infections in "noninfectious" lung diseases.Respiratory review of 2014: tuberculosis and nontuberculous mycobacterial pulmonary disease.Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.Comparison of clinical and radiographic characteristics between nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse panbronchiolitis.Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.Update in tuberculosis 2006.Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet?Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease Comparative genome analyses of Mycobacterium avium reveal genomic features of its subspecies and strains that cause progression of pulmonary disease.Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes.Use of mefloquine in multidrug-resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient.Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease Pulmonary disease caused by nontuberculous mycobacteria.Antimicrobial treatment of non-cystic fibrosis bronchiectasis.Drug susceptibility testing of nontuberculous mycobacteria.Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.Antibiotic treatment for nontuberculous mycobacterial lung disease.Rifabutin: where do we stand in 2016?

P2860

Q26739184-798F715C-B619-49AD-B55F-A380EC080599 Q26748674-D9BA8B2B-19D5-4C32-A10C-517A18B04346 Q26749480-977B3EC3-4FD9-47F9-8DFC-7E7139FE7DD8 Q26775974-B0A5B546-C6D2-40D6-80CF-B67A78096CD4 Q27693348-74464E4D-5D03-4157-9D85-98E265E229E0 Q28071355-B77F1988-907E-4DEE-8C3C-29DC9FB570E8 Q28265322-769F25B9-89D0-4DCC-8D63-448569B06331 Q28552480-684A2A8F-544D-4DD5-9068-1FA5EE6B90B0 Q33995275-6E03F601-EE93-42E5-833F-55CB2F8ACF14 Q34335659-1A302CEB-A418-4307-93CD-8C69FC87D98C Q34357445-29F58636-0B39-4C2C-A101-9F83EF4FC0DE Q34440066-E0D0657A-5693-4202-A4DC-29FBE1C591A4 Q34682886-2836330C-CFB1-4575-A328-1C60372493B2 Q34988090-D49094B2-2846-45F8-B702-5E3785DF4A00 Q35819534-CD731AD3-AF4D-4D3A-92B8-E354D5C3EE83 Q35906474-F409862E-0063-49C0-8BB9-9B969416E23B Q35959926-58683956-5D85-44DD-8E71-B7B349BC7F34 Q36156072-9923BBA7-481E-4C12-B35C-C0034E5D8FEE Q36411147-B5ECE785-A9CC-4F1C-9732-6C9E92A922CC Q36411357-F6555F01-61F0-46D6-A2D3-E97CDBFF81CC Q36567746-44BD5030-52D0-42B0-A67E-A87B89952187 Q36620889-6FB9FBD6-3F05-434C-B2A8-182F61A05803 Q36753136-483ECBA0-16C0-4E27-821F-43829962A9A2 Q36785858-1A8CC6A5-9F78-4EF3-8432-9A991EAF87D3 Q36971020-4D978D99-AAE6-46F6-887F-D5438BDC6C19 Q37086326-75C70C88-E399-46A4-8333-464452EA2CA9 Q37264308-D72E6315-BA4F-4E1C-AE43-0D98F744FCAD Q37304358-C2F8F63B-FBED-4077-8B6C-96CAC7C30A13 Q37305600-117A4D93-578C-4A31-91BA-8303540FA378 Q37358685-AA8B6A43-DE0E-4122-8152-26F283B2FF79 Q37550518-9EB06699-51A0-4984-BE7B-67D502313739 Q37627857-C0FFB77F-8776-4B87-8E1B-CE6683750FE4 Q37672748-8DED1220-ECAB-4FB6-AA85-8A8AD4A405C6 Q37679773-1ACC8829-C664-4C15-807B-330A4FB690C0 Q38066978-7171D84E-41BF-4EFD-8C7B-6DD566AD752B Q38243206-0163DA3F-A85A-457F-BF1D-018F89CBB166 Q38262208-4538C895-D000-4182-9052-BFCA69EC63D5 Q38581888-D9A8331F-5C61-4F05-9953-86C97A25500D Q38770072-E95A1C2C-598D-4EA5-87F5-EBB263FCC01F Q38786540-9DD43A8B-B2F7-4F1A-BF06-5733B1DC3EB0

P2860

Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

http://www.wikidata.org/entity/Q36542587

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Clinical and molecular analysi ...... um avium complex lung disease.

@ast

Clinical and molecular analysi ...... um avium complex lung disease.

@en

type

label

Clinical and molecular analysi ...... um avium complex lung disease.

@ast

Clinical and molecular analysi ...... um avium complex lung disease.

@en

prefLabel

Clinical and molecular analysi ...... um avium complex lung disease.

@ast

Clinical and molecular analysi ...... um avium complex lung disease.

@en

P1433

Q36542587-6AFDC383-A790-4B80-93B3-CCAF114B4F82

P1476

Q36542587-B1BBA3AF-6263-404A-9D3E-A1AB1C59C7B4

P2093

Q36542587-0DF2B9F7-928F-4E80-AAC8-22407C4D4996

Q36542587-15A25CFF-E391-40EC-81E6-978EE672F3BD

Q36542587-27B4AA4C-560B-45BA-AD4F-D5C8E947BB35

Q36542587-6C889B98-96D4-4ABB-8AB7-63FD11451A4C

Q36542587-7295F4EA-9661-4118-A930-26ED4219289A

Q36542587-78EB0081-37AD-4579-A787-01656927F3A2

Q36542587-949CFC24-C81A-44E7-808D-99CB853D03A3

Q36542587-9ECB8728-651E-4BD3-8624-2B32CBE2134E

Q36542587-A05DF05C-4962-42DB-9423-A280DCA3C0A7

Q36542587-ACC2FCF0-4BD0-421B-91CB-ACCB78518CCF

P304

Q36542587-2D6D22F9-946D-4BA7-9E88-C073DA3B32E1

P31

Q36542587-9DA09010-8BFE-472B-BE1B-5FD81087E964

P356

Q36542587-B5943912-4EF3-4F61-BDA7-CAB67F7C3C6C

P407

Q36542587-4D5F6361-2C4C-4D6A-B37F-DA0A84F2BC6D

P433

Q36542587-C397E5A2-4AC4-4518-8F5A-A6FA80F8B88F

P478

Q36542587-F3CB5699-DAD2-4988-BD50-AA9E00E05073

P577

Q36542587-E10E3730-E6CC-4610-95A6-B5619C009DA8

P698

Q36542587-BA7B87DC-4BA2-4484-9009-8CF31EA4E289

P356

RCCM.200603-450OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Clinical and molecular analysi ...... um avium complex lung disease.

@en

P2093

Barbara A Brown-Elliott

http://www.w3.org/2001/XMLSchema#string

Brett Langsjoen

http://www.w3.org/2001/XMLSchema#string

David E Griffith

http://www.w3.org/2001/XMLSchema#string

Edward A Graviss

http://www.w3.org/2001/XMLSchema#string

James Caccitolo

http://www.w3.org/2001/XMLSchema#string

Julio Alvarez

http://www.w3.org/2001/XMLSchema#string

Kenwyn Nelson

http://www.w3.org/2001/XMLSchema#string

Rebecca Wilson

http://www.w3.org/2001/XMLSchema#string

Richard J Wallace

http://www.w3.org/2001/XMLSchema#string

Sara Shepherd

http://www.w3.org/2001/XMLSchema#string

P304

928-934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200603-450OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16858014

http://www.w3.org/2001/XMLSchema#string